Triveni Bio Appoints Bhaskar Srivastava, M.D., Ph.D., as Chief Medical Officer, Announces Key Program Updates

–Immunology and dermatology leader brings deep expertise in atopic dermatitis (AD) as Triveni advances lead program toward the clinic in first half 2025– –Lead asset (TRIV-509) shows superior efficacy relative to IL-4R inhibition in multiple preclinical models– –Company announces second generation approaches, including anti-kallikrein 5/7+IL-13 bispecific– WATERTOWN, Mass., June 12, 2024 – Triveni Bio Inc., a […] The post Triveni Bio Appoints Bhaskar Srivastava, M.D., Ph.D., as Chief Medical Officer, Announces Key Program Updates appeared first on Triveni Bio .